Contraceptives Drugs and Devices Market, Global Outlook and Forecast 2022-2028

Publisher Name :
Date: 26-Jan-2022
No. of pages: 78

Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects.

This report contains market size and forecasts of Contraceptives Drugs and Devices in global, including the following market information:

Global Contraceptives Drugs and Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Contraceptives Drugs and Devices Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Contraceptives Drugs and Devices companies in 2021 (%)

The global Contraceptives Drugs and Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Contraceptives Drugs and Devices include Teva Pharmaceutical Industries Ltd, Church & Dwight Co. Inc, Reckitt Benckiser Plc, Pfizer, Inc, Bayer AG, Mayer Laboratories, Inc, The Female Health Company, Cooper Surgical, Inc and Allergan plc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Contraceptives Drugs and Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Contraceptives Drugs and Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Contraceptives Drugs and Devices Market Segment Percentages, by Type, 2021 (%)

- Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)

- Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)

Global Contraceptives Drugs and Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Contraceptives Drugs and Devices Market Segment Percentages, by Application, 2021 (%)

- Female

- Male

Global Contraceptives Drugs and Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Contraceptives Drugs and Devices Market Segment Percentages, By Region and Country, 2021 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Contraceptives Drugs and Devices revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Contraceptives Drugs and Devices revenues share in global market, 2021 (%)

Key companies Contraceptives Drugs and Devices sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Contraceptives Drugs and Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Teva Pharmaceutical Industries Ltd

- Church & Dwight Co. Inc

- Reckitt Benckiser Plc

- Pfizer, Inc

- Bayer AG

- Mayer Laboratories, Inc

- The Female Health Company

- Cooper Surgical, Inc

- Allergan plc

- Cipla Limited

- Merck & Co. Inc

Contraceptives Drugs and Devices Market, Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Contraceptives Drugs and Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Contraceptives Drugs and Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Contraceptives Drugs and Devices Overall Market Size
2.1 Global Contraceptives Drugs and Devices Market Size: 2021 VS 2028
2.2 Global Contraceptives Drugs and Devices Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Contraceptives Drugs and Devices Sales: 2017-2028
3 Company Landscape
3.1 Top Contraceptives Drugs and Devices Players in Global Market
3.2 Top Global Contraceptives Drugs and Devices Companies Ranked by Revenue
3.3 Global Contraceptives Drugs and Devices Revenue by Companies
3.4 Global Contraceptives Drugs and Devices Sales by Companies
3.5 Global Contraceptives Drugs and Devices Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Contraceptives Drugs and Devices Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Contraceptives Drugs and Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Contraceptives Drugs and Devices Players in Global Market
3.8.1 List of Global Tier 1 Contraceptives Drugs and Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Contraceptives Drugs and Devices Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Contraceptives Drugs and Devices Market Size Markets, 2021 & 2028
4.1.2 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
4.1.3 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
4.2 By Type - Global Contraceptives Drugs and Devices Revenue & Forecasts
4.2.1 By Type - Global Contraceptives Drugs and Devices Revenue, 2017-2022
4.2.2 By Type - Global Contraceptives Drugs and Devices Revenue, 2023-2028
4.2.3 By Type - Global Contraceptives Drugs and Devices Revenue Market Share, 2017-2028
4.3 By Type - Global Contraceptives Drugs and Devices Sales & Forecasts
4.3.1 By Type - Global Contraceptives Drugs and Devices Sales, 2017-2022
4.3.2 By Type - Global Contraceptives Drugs and Devices Sales, 2023-2028
4.3.3 By Type - Global Contraceptives Drugs and Devices Sales Market Share, 2017-2028
4.4 By Type - Global Contraceptives Drugs and Devices Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Contraceptives Drugs and Devices Market Size, 2021 & 2028
5.1.2 Female
5.1.3 Male
5.2 By Application - Global Contraceptives Drugs and Devices Revenue & Forecasts
5.2.1 By Application - Global Contraceptives Drugs and Devices Revenue, 2017-2022
5.2.2 By Application - Global Contraceptives Drugs and Devices Revenue, 2023-2028
5.2.3 By Application - Global Contraceptives Drugs and Devices Revenue Market Share, 2017-2028
5.3 By Application - Global Contraceptives Drugs and Devices Sales & Forecasts
5.3.1 By Application - Global Contraceptives Drugs and Devices Sales, 2017-2022
5.3.2 By Application - Global Contraceptives Drugs and Devices Sales, 2023-2028
5.3.3 By Application - Global Contraceptives Drugs and Devices Sales Market Share, 2017-2028
5.4 By Application - Global Contraceptives Drugs and Devices Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Contraceptives Drugs and Devices Market Size, 2021 & 2028
6.2 By Region - Global Contraceptives Drugs and Devices Revenue & Forecasts
6.2.1 By Region - Global Contraceptives Drugs and Devices Revenue, 2017-2022
6.2.2 By Region - Global Contraceptives Drugs and Devices Revenue, 2023-2028
6.2.3 By Region - Global Contraceptives Drugs and Devices Revenue Market Share, 2017-2028
6.3 By Region - Global Contraceptives Drugs and Devices Sales & Forecasts
6.3.1 By Region - Global Contraceptives Drugs and Devices Sales, 2017-2022
6.3.2 By Region - Global Contraceptives Drugs and Devices Sales, 2023-2028
6.3.3 By Region - Global Contraceptives Drugs and Devices Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Contraceptives Drugs and Devices Revenue, 2017-2028
6.4.2 By Country - North America Contraceptives Drugs and Devices Sales, 2017-2028
6.4.3 US Contraceptives Drugs and Devices Market Size, 2017-2028
6.4.4 Canada Contraceptives Drugs and Devices Market Size, 2017-2028
6.4.5 Mexico Contraceptives Drugs and Devices Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Contraceptives Drugs and Devices Revenue, 2017-2028
6.5.2 By Country - Europe Contraceptives Drugs and Devices Sales, 2017-2028
6.5.3 Germany Contraceptives Drugs and Devices Market Size, 2017-2028
6.5.4 France Contraceptives Drugs and Devices Market Size, 2017-2028
6.5.5 U.K. Contraceptives Drugs and Devices Market Size, 2017-2028
6.5.6 Italy Contraceptives Drugs and Devices Market Size, 2017-2028
6.5.7 Russia Contraceptives Drugs and Devices Market Size, 2017-2028
6.5.8 Nordic Countries Contraceptives Drugs and Devices Market Size, 2017-2028
6.5.9 Benelux Contraceptives Drugs and Devices Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Contraceptives Drugs and Devices Revenue, 2017-2028
6.6.2 By Region - Asia Contraceptives Drugs and Devices Sales, 2017-2028
6.6.3 China Contraceptives Drugs and Devices Market Size, 2017-2028
6.6.4 Japan Contraceptives Drugs and Devices Market Size, 2017-2028
6.6.5 South Korea Contraceptives Drugs and Devices Market Size, 2017-2028
6.6.6 Southeast Asia Contraceptives Drugs and Devices Market Size, 2017-2028
6.6.7 India Contraceptives Drugs and Devices Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Contraceptives Drugs and Devices Revenue, 2017-2028
6.7.2 By Country - South America Contraceptives Drugs and Devices Sales, 2017-2028
6.7.3 Brazil Contraceptives Drugs and Devices Market Size, 2017-2028
6.7.4 Argentina Contraceptives Drugs and Devices Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Contraceptives Drugs and Devices Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Contraceptives Drugs and Devices Sales, 2017-2028
6.8.3 Turkey Contraceptives Drugs and Devices Market Size, 2017-2028
6.8.4 Israel Contraceptives Drugs and Devices Market Size, 2017-2028
6.8.5 Saudi Arabia Contraceptives Drugs and Devices Market Size, 2017-2028
6.8.6 UAE Contraceptives Drugs and Devices Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Teva Pharmaceutical Industries Ltd
7.1.1 Teva Pharmaceutical Industries Ltd Corporate Summary
7.1.2 Teva Pharmaceutical Industries Ltd Business Overview
7.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Major Product Offerings
7.1.4 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales and Revenue in Global (2017-2022)
7.1.5 Teva Pharmaceutical Industries Ltd Key News
7.2 Church & Dwight Co. Inc
7.2.1 Church & Dwight Co. Inc Corporate Summary
7.2.2 Church & Dwight Co. Inc Business Overview
7.2.3 Church & Dwight Co. Inc Contraceptives Drugs and Devices Major Product Offerings
7.2.4 Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales and Revenue in Global (2017-2022)
7.2.5 Church & Dwight Co. Inc Key News
7.3 Reckitt Benckiser Plc
7.3.1 Reckitt Benckiser Plc Corporate Summary
7.3.2 Reckitt Benckiser Plc Business Overview
7.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Major Product Offerings
7.3.4 Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales and Revenue in Global (2017-2022)
7.3.5 Reckitt Benckiser Plc Key News
7.4 Pfizer, Inc
7.4.1 Pfizer, Inc Corporate Summary
7.4.2 Pfizer, Inc Business Overview
7.4.3 Pfizer, Inc Contraceptives Drugs and Devices Major Product Offerings
7.4.4 Pfizer, Inc Contraceptives Drugs and Devices Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer, Inc Key News
7.5 Bayer AG
7.5.1 Bayer AG Corporate Summary
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Contraceptives Drugs and Devices Major Product Offerings
7.5.4 Bayer AG Contraceptives Drugs and Devices Sales and Revenue in Global (2017-2022)
7.5.5 Bayer AG Key News
7.6 Mayer Laboratories, Inc
7.6.1 Mayer Laboratories, Inc Corporate Summary
7.6.2 Mayer Laboratories, Inc Business Overview
7.6.3 Mayer Laboratories, Inc Contraceptives Drugs and Devices Major Product Offerings
7.6.4 Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales and Revenue in Global (2017-2022)
7.6.5 Mayer Laboratories, Inc Key News
7.7 The Female Health Company
7.7.1 The Female Health Company Corporate Summary
7.7.2 The Female Health Company Business Overview
7.7.3 The Female Health Company Contraceptives Drugs and Devices Major Product Offerings
7.7.4 The Female Health Company Contraceptives Drugs and Devices Sales and Revenue in Global (2017-2022)
7.7.5 The Female Health Company Key News
7.8 Cooper Surgical, Inc
7.8.1 Cooper Surgical, Inc Corporate Summary
7.8.2 Cooper Surgical, Inc Business Overview
7.8.3 Cooper Surgical, Inc Contraceptives Drugs and Devices Major Product Offerings
7.8.4 Cooper Surgical, Inc Contraceptives Drugs and Devices Sales and Revenue in Global (2017-2022)
7.8.5 Cooper Surgical, Inc Key News
7.9 Allergan plc
7.9.1 Allergan plc Corporate Summary
7.9.2 Allergan plc Business Overview
7.9.3 Allergan plc Contraceptives Drugs and Devices Major Product Offerings
7.9.4 Allergan plc Contraceptives Drugs and Devices Sales and Revenue in Global (2017-2022)
7.9.5 Allergan plc Key News
7.10 Cipla Limited
7.10.1 Cipla Limited Corporate Summary
7.10.2 Cipla Limited Business Overview
7.10.3 Cipla Limited Contraceptives Drugs and Devices Major Product Offerings
7.10.4 Cipla Limited Contraceptives Drugs and Devices Sales and Revenue in Global (2017-2022)
7.10.5 Cipla Limited Key News
7.11 Merck & Co. Inc
7.11.1 Merck & Co. Inc Corporate Summary
7.11.2 Merck & Co. Inc Contraceptives Drugs and Devices Business Overview
7.11.3 Merck & Co. Inc Contraceptives Drugs and Devices Major Product Offerings
7.11.4 Merck & Co. Inc Contraceptives Drugs and Devices Sales and Revenue in Global (2017-2022)
7.11.5 Merck & Co. Inc Key News
8 Global Contraceptives Drugs and Devices Production Capacity, Analysis
8.1 Global Contraceptives Drugs and Devices Production Capacity, 2017-2028
8.2 Contraceptives Drugs and Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Contraceptives Drugs and Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Contraceptives Drugs and Devices Supply Chain Analysis
10.1 Contraceptives Drugs and Devices Industry Value Chain
10.2 Contraceptives Drugs and Devices Upstream Market
10.3 Contraceptives Drugs and Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Contraceptives Drugs and Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Contraceptives Drugs and Devices in Global Market
Table 2. Top Contraceptives Drugs and Devices Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Contraceptives Drugs and Devices Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Contraceptives Drugs and Devices Revenue Share by Companies, 2017-2022
Table 5. Global Contraceptives Drugs and Devices Sales by Companies, (K Units), 2017-2022
Table 6. Global Contraceptives Drugs and Devices Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Contraceptives Drugs and Devices Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Contraceptives Drugs and Devices Product Type
Table 9. List of Global Tier 1 Contraceptives Drugs and Devices Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Contraceptives Drugs and Devices Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Contraceptives Drugs and Devices Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Contraceptives Drugs and Devices Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Contraceptives Drugs and Devices Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Contraceptives Drugs and Devices Sales (K Units), 2017-2022
Table 15. By Type - Global Contraceptives Drugs and Devices Sales (K Units), 2023-2028
Table 16. By Application - Global Contraceptives Drugs and Devices Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Contraceptives Drugs and Devices Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Contraceptives Drugs and Devices Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Contraceptives Drugs and Devices Sales (K Units), 2017-2022
Table 20. By Application - Global Contraceptives Drugs and Devices Sales (K Units), 2023-2028
Table 21. By Region - Global Contraceptives Drugs and Devices Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Contraceptives Drugs and Devices Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Contraceptives Drugs and Devices Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Contraceptives Drugs and Devices Sales (K Units), 2017-2022
Table 25. By Region - Global Contraceptives Drugs and Devices Sales (K Units), 2023-2028
Table 26. By Country - North America Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Contraceptives Drugs and Devices Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Contraceptives Drugs and Devices Sales, (K Units), 2017-2022
Table 29. By Country - North America Contraceptives Drugs and Devices Sales, (K Units), 2023-2028
Table 30. By Country - Europe Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Contraceptives Drugs and Devices Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Contraceptives Drugs and Devices Sales, (K Units), 2017-2022
Table 33. By Country - Europe Contraceptives Drugs and Devices Sales, (K Units), 2023-2028
Table 34. By Region - Asia Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Contraceptives Drugs and Devices Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Contraceptives Drugs and Devices Sales, (K Units), 2017-2022
Table 37. By Region - Asia Contraceptives Drugs and Devices Sales, (K Units), 2023-2028
Table 38. By Country - South America Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Contraceptives Drugs and Devices Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Contraceptives Drugs and Devices Sales, (K Units), 2017-2022
Table 41. By Country - South America Contraceptives Drugs and Devices Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Contraceptives Drugs and Devices Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Contraceptives Drugs and Devices Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Contraceptives Drugs and Devices Sales, (K Units), 2023-2028
Table 46. Teva Pharmaceutical Industries Ltd Corporate Summary
Table 47. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Offerings
Table 48. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Church & Dwight Co. Inc Corporate Summary
Table 50. Church & Dwight Co. Inc Contraceptives Drugs and Devices Product Offerings
Table 51. Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Reckitt Benckiser Plc Corporate Summary
Table 53. Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Offerings
Table 54. Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Pfizer, Inc Corporate Summary
Table 56. Pfizer, Inc Contraceptives Drugs and Devices Product Offerings
Table 57. Pfizer, Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Bayer AG Corporate Summary
Table 59. Bayer AG Contraceptives Drugs and Devices Product Offerings
Table 60. Bayer AG Contraceptives Drugs and Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Mayer Laboratories, Inc Corporate Summary
Table 62. Mayer Laboratories, Inc Contraceptives Drugs and Devices Product Offerings
Table 63. Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. The Female Health Company Corporate Summary
Table 65. The Female Health Company Contraceptives Drugs and Devices Product Offerings
Table 66. The Female Health Company Contraceptives Drugs and Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Cooper Surgical, Inc Corporate Summary
Table 68. Cooper Surgical, Inc Contraceptives Drugs and Devices Product Offerings
Table 69. Cooper Surgical, Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Allergan plc Corporate Summary
Table 71. Allergan plc Contraceptives Drugs and Devices Product Offerings
Table 72. Allergan plc Contraceptives Drugs and Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Cipla Limited Corporate Summary
Table 74. Cipla Limited Contraceptives Drugs and Devices Product Offerings
Table 75. Cipla Limited Contraceptives Drugs and Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Merck & Co. Inc Corporate Summary
Table 77. Merck & Co. Inc Contraceptives Drugs and Devices Product Offerings
Table 78. Merck & Co. Inc Contraceptives Drugs and Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Contraceptives Drugs and Devices Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 80. Global Contraceptives Drugs and Devices Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Contraceptives Drugs and Devices Production by Region, 2017-2022 (K Units)
Table 82. Global Contraceptives Drugs and Devices Production by Region, 2023-2028 (K Units)
Table 83. Contraceptives Drugs and Devices Market Opportunities & Trends in Global Market
Table 84. Contraceptives Drugs and Devices Market Drivers in Global Market
Table 85. Contraceptives Drugs and Devices Market Restraints in Global Market
Table 86. Contraceptives Drugs and Devices Raw Materials
Table 87. Contraceptives Drugs and Devices Raw Materials Suppliers in Global Market
Table 88. Typical Contraceptives Drugs and Devices Downstream
Table 89. Contraceptives Drugs and Devices Downstream Clients in Global Market
Table 90. Contraceptives Drugs and Devices Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Contraceptives Drugs and Devices Segment by Type
Figure 2. Contraceptives Drugs and Devices Segment by Application
Figure 3. Global Contraceptives Drugs and Devices Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Contraceptives Drugs and Devices Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Contraceptives Drugs and Devices Revenue, 2017-2028 (US$, Mn)
Figure 7. Contraceptives Drugs and Devices Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Contraceptives Drugs and Devices Revenue in 2021
Figure 9. By Type - Global Contraceptives Drugs and Devices Sales Market Share, 2017-2028
Figure 10. By Type - Global Contraceptives Drugs and Devices Revenue Market Share, 2017-2028
Figure 11. By Type - Global Contraceptives Drugs and Devices Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Contraceptives Drugs and Devices Sales Market Share, 2017-2028
Figure 13. By Application - Global Contraceptives Drugs and Devices Revenue Market Share, 2017-2028
Figure 14. By Application - Global Contraceptives Drugs and Devices Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Contraceptives Drugs and Devices Sales Market Share, 2017-2028
Figure 16. By Region - Global Contraceptives Drugs and Devices Revenue Market Share, 2017-2028
Figure 17. By Country - North America Contraceptives Drugs and Devices Revenue Market Share, 2017-2028
Figure 18. By Country - North America Contraceptives Drugs and Devices Sales Market Share, 2017-2028
Figure 19. US Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Contraceptives Drugs and Devices Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Contraceptives Drugs and Devices Sales Market Share, 2017-2028
Figure 24. Germany Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 25. France Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Contraceptives Drugs and Devices Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Contraceptives Drugs and Devices Sales Market Share, 2017-2028
Figure 33. China Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 37. India Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Contraceptives Drugs and Devices Revenue Market Share, 2017-2028
Figure 39. By Country - South America Contraceptives Drugs and Devices Sales Market Share, 2017-2028
Figure 40. Brazil Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Contraceptives Drugs and Devices Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Contraceptives Drugs and Devices Sales Market Share, 2017-2028
Figure 44. Turkey Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Contraceptives Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 48. Global Contraceptives Drugs and Devices Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Contraceptives Drugs and Devices by Region, 2021 VS 2028
Figure 50. Contraceptives Drugs and Devices Industry Value Chain
Figure 51. Marketing Channels
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs